Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 04/29/2024 at 14:39, 1 year 7 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces the implementation of a dedicated partnership strategy in obesity, aiming to collaborate with global pharmaceutical companies for drug development and commercialization. CEO Stanislas Veillet emphasizes the importance of addressing the obesity medical challenge through partnerships

Biophytis Drug Development Obesity Partnership Strategy Pharmaceutical Companies
BRIEF

published on 04/29/2024 at 07:05, 1 year 7 months ago

Biophytis Advances Partnership Strategy in Obesity Sector

Biophytis Obesity Treatment Healthcare Innovation Pharmaceutical Partnerships BIO101
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 1 year 7 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 1 year 7 months ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 7 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 7 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 1 year 7 months ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 1 year 7 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt (ADR) program, with effective date expected to be April 23, 2024

Biophytis Stock Market American Depositary Receipt ADR Program Ratio Change
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 1 year 7 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt program, affecting ADS to Shares ratio. No new shares issued, trading price may increase. Details provided in the press release

Biophytis Shares Ads American Depositary Receipt Ratio Change
BRIEF

published on 04/18/2024 at 07:05, 1 year 7 months ago

Biophytis Announces New Scientific Advisory Board for Phase 2 Obesity Study

Biophytis Scientific Advisory Board BIO101 Obesity OBA Clinical Study

Accesswire

Published on 12/05/2025 at 20:25, 31 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 41 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 6 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 36 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 11 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 58 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 29 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 40 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 4 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 10 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 38 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 45 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 12 hours 11 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day 2 hours ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day 3 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE